Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Clinical Neurophysiologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
July 23, 2007
Device attacks ischemic stroke without mercy
Analysis of: Multi MERCI(R) Trial Demonstrates Better Outcomes For Patients Suffering Ischemic Stroke | www.medicalnewstoday.com
Author: GLG Expert Contributor
The article reports on the results of recent research showing the effectiveness of the Merci(R) Retrieval System.  This pivotal study has contributed to the device receiving FDA approval
May 30, 2007
Pulsed radiofrequency (PRF) in treating chronic back pain seems effective.
Analysis of: New Treatment Offers Relief from Chronic Back Pain - Study Suggests Safe Treatment for a Variety of Conditions | www.medicalnewstoday.com
Author: GLG Expert Contributor
(1) Chronic back pain is a challenge to treat with limited options. (2) The emergence of new therapies to help support efforts at physiotherapy are certainly hopeful signs for those with refractory pain. (3) There are concerns about this specific treatment, PRF.
May 28, 2007
Pulsed radiofrequency (PRF) in treating chronic back pain seems effective.
Analysis of: New Treatment Offers Relief from Chronic Back Pain - Study Suggests Safe Treatment for a Variety of Conditions | www.medicalnewstoday.com
Author: GLG Expert Contributor
(1) Chronic back pain is a challenge to treat with limited options. (2) The emergence of new therapies to help support efforts at physiotherapy are certainly hopeful signs for those with refractory pain. (3) There are concerns about this specific treatment, PRF.
May 23, 2007
PCR Used to Detect Bad Meat
Analysis of: New Test May Allow For Rapid Detection Of Salmonella In Meat | www.medicalnewstoday.com
Author: GLG Expert Contributor
PCR analysis of meat for Salmonella was compared to traditional culture methods The PCR technique showed a relatively high sensitivity and specificity for the organism much more rapidly
May 3, 2007
TRA-SCH 530348 in preventing vascular thrombotic events
Analysis of: Major phase 3 program planned for new antiplatelet drug | www.theheart.org
Author: GLG Expert Contributor
(1) TRA-SCH 530348 has a novel mechanism of action. (2) Many antiplatelet agents (and anticoagulation therapies) are available with differences based on ability to prevent clotting and risk of systemic hemorrhage. (3) Unclear what the benefits or risks of new agents will be until assessed in controlled...
April 3, 2007
Lamotrigine superior for partial epilepsy?
Analysis of: Research Finds Newer Drug for Partial Epilepsy Is Superior But Old Tops New For Generalised Seizures | www.medicalnewstoday.com
Author: GLG Expert Contributor
  The article reports on a British study suggesting that lamotrigine and valproic acid are respectively the best first line drugs for partial and generalized onset epilepsy.
April 3, 2007
Avicena begins NIH funded phase III trial of PD-02
Analysis of: Avicena Announces Patient Enrollment in National Institutes Of Health (NIH) Phase III Parkinson's Disease Trial | www.medicalnewstoday.com
Author: GLG Expert Contributor
  PD-02 is an ultra-pure form of creatine which may slow the progress of Parkinson’s Disease. A federal government sponsored phase III clinical trial has just begun to evaluate its efficacy.
April 3, 2007
Cox-2 inhibitor comeback?
Analysis of: Suffering boomers want to fill Vioxx void | www.contracostatimes.com
Author: GLG Expert Contributor
  The article states that Cox-2 inhibitors may be making a comeback to treat arthritis pain
April 3, 2007
Duloxetine (Cymbalta) gets new FDA approval
Analysis of: FDA Approves Duloxetine for Anxiety | journals.elsevierhealth.com
Author: GLG Expert Contributor
  Duloxetine has received FDA approval for the treatment of generalized anxiety disorder, based on the results of three studies of more than 800 subjects.
April 3, 2007
Anterior plating has higher fusion rate for single-disc-level procedures
Analysis of: Study Compares Benefits Of Surgical Treatments For Degenerative Spinal Disease - Higher Success Rates Shown In Procedures Using Plate System | www.medicalnewstoday.com
Author: GLG Expert Contributor
 This article reports on a meta-analysis comparing different surgical procedures for cervical fusion. Approaches with anterior plating provided the highest rates of fusion.

Previous Page : 1 2 3 4 5 Next21 to 30 of 46

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T05:45:17.133